Literature DB >> 8499922

Identification of two point mutations and a one base deletion in exon 19 of the dystrophin gene by heteroduplex formation.

T W Prior1, A C Papp, P J Snyder, A H Burghes, M S Sedra, L M Western, C Bartello, J R Mendell.   

Abstract

Two thirds of the Duchenne muscular dystrophy population have either gene deletions or duplications. The nondeletion/duplication cases are most likely the result of point mutations or small deletions and duplications that cannot be easily identified by current strategies. The major obstacle in identifying small mutations is due to the large size of the dystrophin gene. We selectively screened 5 DMD exons containing CpG dinucleotides in 110 DMD patients without detectable deletions or duplications. Nonsenses mutations are frequently due to a C- to -T transition within a CG dinucleotide pair. To screen for the nonsense mutations, we used the heteroduplex method. Utilizing this approach, we identified 2 different nonsense mutations and a single base deletion all occurring in exon 19. This is the first report of a clustering of small mutations in the dystrophin gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499922     DOI: 10.1093/hmg/2.3.311

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

1.  Pizza, pepsi, and picking postgraduates.

Authors:  K Gundling
Journal:  West J Med       Date:  1993-03

2.  Heteroduplex analysis detects frameshift and point mutations in patients with acute intermittent porphyria.

Authors:  W E Schreiber; F Fong; B A Nassar; A Jamani
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

3.  Detection of an exon 53 polymorphism in the dystrophin gene.

Authors:  T W Prior; A C Papp; P J Snyder; M S Sedra
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

Review 4.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

Authors:  J M Musser
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Splicing mutations in DMD/BMD detected by RT-PCR/PTT: detection of a 19AA insertion in the cysteine rich domain of dystrophin compatible with BMD.

Authors:  P A Roest; M Bout; A C van der Tuijn; I B Ginjaar; E Bakker; F B Hogervorst; G J van Ommen; J T den Dunnen
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

6.  Microlesions and polymorphisms in the Duchenne/Becker muscular dystrophy gene.

Authors:  F Rininsland; J Reiss
Journal:  Hum Genet       Date:  1994-08       Impact factor: 4.132

7.  Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.

Authors:  M Upadhyaya; J Maynard; M Osborn; S M Huson; M Ponder; B A Ponder; P S Harper
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

8.  Characterization of rifampin-resistance in pathogenic mycobacteria.

Authors:  D L Williams; C Waguespack; K Eisenach; J T Crawford; F Portaels; M Salfinger; C M Nolan; C Abe; V Sticht-Groh; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.